FDA and FTC warned Holistic Healer & Wellness Center that Diabalance Diabetes Supplement claims make it an unapproved new drug.
What happened
FDA reviewed the company’s website in August 2021 and found it took orders for Diabalance Diabetes Supplement. FDA said website claims that the product helps balance blood sugar and treat diabetes make it a drug intended to treat disease, an unapproved new drug, and misbranded for lacking adequate directions. FTC also reviewed the website in August 2021 and said the diabetes treatment claims may lack competent and reliable scientific evidence.
What FDA found
The product is a drug because its website claims show it is intended to diagnose, cure, mitigate, treat, or prevent disease.
section 201(g)(1)(B) of the Act [21 U.S.C. 321(g)(1)(B)]The product is a new drug because it is not generally recognized as safe and effective for those uses and has no FDA approval.
sections 201(p), 301(d), and 505(a) of the Act [21 U.S.C. 321(p), 331(d), 355(a)]The product is misbranded because it lacks enough directions for a layperson to use it safely; diabetes treatment is not suitable for self-diagnosis or self-treatment without a licensed practitioner.
section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]; 21 CFR 201.5Introducing the misbranded drug into interstate commerce violates the Act.
section 301(a) of the Act [21 U.S.C. 331(a)]FTC says the company must stop claiming the product can prevent, treat, or cure diabetes without competent and reliable scientific evidence, including well-controlled human clinical studies.
FTC Act, 15 U.S.C. § 41 et seq.
What FDA wants
FDA asks the company to notify it in writing within 15 working days of receipt of the letter about specific steps taken to address the violations, including an explanation, documentation, and steps to prevent recurrence; if corrective action cannot be completed in that time, state the reason and when it will be done.
Who should pay attention
- dietary supplement brands making disease treatment claims
- retailers and online marketplaces selling diabetes supplements
- consumers and caregivers managing diabetes
This is a summary. Read the original letter on fda.gov.